ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
July 21, 2021Imago BioSciences, Inc. today announced the closing of $134.4 million in gross proceeds from its previously announced initial public offering and $20.0 million in gross proceeds from its concurrent private placement. -
Imago BioSciences Completes Enrollment in IMG-7289 Study
August 22, 2018Imago BioSciences announced the Phase 1/2a clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) has fully enrolled at 45 patients.
Pharma Sources Insight January 2025
